More on FLML

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Holders
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

FLML Income Statement

Click line-items for a historical chart and %
Product sales and services 31.34M
License and research revenue 747K
Total 32.09M
Cost of products and services sold 2.84M
Research and development expenses 8.14M
Selling, general and administrative expenses 12.74M
Intangible asset amortization 3.7M
Changes in fair value of related party acquisition-related contingent consideration 20.85M
Total 48.28M
Operating income (loss) -16.19M
Investment Income 490K
Interest Expense -264K
Interest Expense - changes in fair value of financing-related contingent consideration -1.83M
Foreign exchange gain (loss) 1.25M
Income (loss) before income taxes -16.54M
Income tax provision (benefit) 3.45M
Net income (loss) -19.99M
Continuing operations
Discontinued operations
Net income (loss) -0.48
Continuing operations
Discontinued operations
Net income (loss) -0.48
Weighted average number of shares outstanding - Basic (in shares) 41.24M
Weighted average number of shares outstanding - Diluted (in shares) 41.24M